Sources | Names Used |
---|---|
CCLE, FIMM | Vandetanib |
CTRPv2 | vandetanib |
PharmacoGx | Vandetanib |
Database | Identifier |
---|---|
Smiles: | CN1CCC(CC1)COC2=C(C=C3C(=C2)N=CN=C3NC4=C(C=C(C=C4)Br)F)OC |
Inchikey: | UHTHHESEBZOYNR-UHFFFAOYSA-N |
Pubchem: | 3081361 |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | UNC80 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.006 |
mRNA | AMN1 | CCLE | pan-cancer | AAC | -0.13 | 0.006 |
mRNA | POLRMT | CTRPv2 | pan-cancer | AAC | -0.11 | 0.006 |
mRNA | TINF2 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.006 |
mRNA | ABHD10 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.006 |
mRNA | MMP15 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.006 |
mRNA | LIPK | CTRPv2 | pan-cancer | AAC | 0.098 | 0.006 |
mRNA | ARFGEF1 | CCLE | pan-cancer | AAC | 0.13 | 0.006 |
mRNA | LOR | CCLE | pan-cancer | AAC | 0.13 | 0.006 |
mRNA | C17orf99 | CTRPv2 | pan-cancer | AAC | 0.099 | 0.006 |